N.G. Wahlgren

3.8k total citations
6 papers, 234 citations indexed

About

N.G. Wahlgren is a scholar working on Epidemiology, Cellular and Molecular Neuroscience and Rehabilitation. According to data from OpenAlex, N.G. Wahlgren has authored 6 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Rehabilitation. Recurrent topics in N.G. Wahlgren's work include Acute Ischemic Stroke Management (4 papers), Stroke Rehabilitation and Recovery (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). N.G. Wahlgren is often cited by papers focused on Acute Ischemic Stroke Management (4 papers), Stroke Rehabilitation and Recovery (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). N.G. Wahlgren collaborates with scholars based in Sweden, United Kingdom and Canada. N.G. Wahlgren's co-authors include T. Ashwood, Thierry Rosolacci, L. Claesson, C L Franke, P.M.M. van Erven, Ashfaq Shuaib, Antoni Dávalos, Werner Hacke, S. Holtås and Markku Kaste and has published in prestigious journals such as Stroke, International review of neurobiology and International Journal of Clinical Practice.

In The Last Decade

N.G. Wahlgren

6 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N.G. Wahlgren Sweden 5 119 85 57 51 48 6 234
Thierry Rosolacci France 4 120 1.0× 77 0.9× 31 0.5× 26 0.5× 40 0.8× 5 185
Stephen Phillips Canada 7 147 1.2× 66 0.8× 66 1.2× 79 1.5× 80 1.7× 9 356
P.M.M. van Erven Netherlands 7 84 0.7× 69 0.8× 42 0.7× 148 2.9× 45 0.9× 8 293
David Goldemund Czechia 8 92 0.8× 57 0.7× 28 0.5× 30 0.6× 166 3.5× 10 268
Mohammed I. Oraby Egypt 10 97 0.8× 29 0.3× 17 0.3× 22 0.4× 42 0.9× 22 233
Christopher Goshgarian United States 5 62 0.5× 94 1.1× 9 0.2× 19 0.4× 70 1.5× 11 243
Cécile Preterre France 8 103 0.9× 23 0.3× 18 0.3× 15 0.3× 143 3.0× 12 228
L. Liu China 7 78 0.7× 17 0.2× 19 0.3× 24 0.5× 37 0.8× 20 220
Suchat Hanchaiphiboolkul Thailand 8 80 0.7× 24 0.3× 32 0.6× 28 0.5× 65 1.4× 14 190
Maryam Hosseini Farahabadi United States 6 55 0.5× 111 1.3× 14 0.2× 59 1.2× 70 1.5× 9 273

Countries citing papers authored by N.G. Wahlgren

Since Specialization
Citations

This map shows the geographic impact of N.G. Wahlgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.G. Wahlgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.G. Wahlgren more than expected).

Fields of papers citing papers by N.G. Wahlgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.G. Wahlgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.G. Wahlgren. The network helps show where N.G. Wahlgren may publish in the future.

Co-authorship network of co-authors of N.G. Wahlgren

This figure shows the co-authorship network connecting the top 25 collaborators of N.G. Wahlgren. A scholar is included among the top collaborators of N.G. Wahlgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.G. Wahlgren. N.G. Wahlgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Bath, Philip M., Laura J. Gray, & N.G. Wahlgren. (2007). Should data monitoring committees assess efficacy when considering safety in trials in acute stroke?. International Journal of Clinical Practice. 61(10). 1749–1755. 1 indexed citations
2.
Kaste, Markku, Lars Thomassen, Martin Grond, et al.. (2001). Thrombolysis for Acute Ischemic Stroke: A Consensus Statement of the 3rd Karolinska Stroke Update, October 30 31, 2000. Stroke. 32(11). 2717–2718. 28 indexed citations
3.
Wahlgren, N.G., et al.. (2000). The clomethiazole acute stroke study (CLASS): Safety results in 1,356 patients with acute hemispheric stroke. Journal of Stroke and Cerebrovascular Diseases. 9(4). 158–165. 11 indexed citations
4.
Dávalos, Antoni, Ashfaq Shuaib, & N.G. Wahlgren. (2000). Neurotransmitters and pathophysiology of stroke: Evidence for the release of glutamate and other transmitters/mediators in animals and humans. Journal of Stroke and Cerebrovascular Diseases. 9(6). 2–8. 50 indexed citations
5.
Wahlgren, N.G., Thierry Rosolacci, C L Franke, et al.. (1999). Clomethiazole Acute Stroke Study (CLASS). Stroke. 30(1). 21–28. 125 indexed citations
6.
Wahlgren, N.G.. (1996). Chapter 15 A Review of Earlier Clinical Studies on Neuroprotective Agents and Current Approaches. International review of neurobiology. 40. 337–363. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026